Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
457.40
-1.00 (-0.22%)
Jul 24, 2026, 5:29 PM CET
STO:SOBI Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,082 | 1,041 | 1,140 | 904 | 1,361 | 1,045 |
Cash & Short-Term Investments | 1,082 | 1,041 | 1,140 | 904 | 1,361 | 1,045 |
Cash Growth | 2.27% | -8.68% | 26.11% | -33.58% | 30.24% | 158.66% |
Accounts Receivable | 7,460 | 5,856 | 5,195 | 5,169 | 5,249 | 3,439 |
Other Receivables | 2,431 | 723 | 405 | 602 | 558 | 345 |
Total Trade Receivables | 9,891 | 6,579 | 5,600 | 5,771 | 5,807 | 3,784 |
Inventory | 6,450 | 5,127 | 4,159 | 3,874 | 3,332 | 3,424 |
Other Current Assets | - | 1,781 | 2,262 | 1,611 | 710 | 525 |
Total Current Assets | 17,423 | 14,528 | 13,162 | 12,160 | 11,210 | 8,778 |
Net Property, Plant & Equipment | 1,626 | 1,631 | 1,584 | 1,302 | 274 | 493 |
Other Intangible Assets | 61,303 | 49,080 | 58,971 | 59,580 | 40,013 | 38,424 |
Long-Term Investments | 1,173 | 1,177 | 166 | 142 | 121 | 199 |
Other Long-Term Assets | 1,366 | 1,017 | 1,561 | 844 | 877 | 767 |
Total Assets | 82,891 | 67,434 | 75,444 | 74,027 | 52,496 | 48,661 |
Accounts Payable | 1,955 | 1,235 | 944 | 1,024 | 1,252 | 558 |
Accrued Expenses | - | 6,038 | 5,674 | 5,248 | 5,253 | 4,700 |
Current Portion of Long-Term Debt | 8,725 | 5,942 | 3,926 | 8,813 | 5,796 | 1,768 |
Current Portion of Leases | 128 | 114 | 134 | 148 | 134 | 114 |
Other Current Liabilities | 9,102 | 2,741 | 1,921 | 3,862 | 2,422 | 1,621 |
Total Current Liabilities | 19,910 | 16,069 | 12,600 | 19,095 | 14,857 | 8,761 |
Long-Term Debt | 8,483 | 5,180 | 12,407 | 11,356 | 2,971 | 8,777 |
Long-Term Leases | 251 | 259 | 268 | 168 | 200 | 247 |
Other Long-Term Liabilities | 11,979 | 8,203 | 9,872 | 9,541 | 7,942 | 7,673 |
Total Long-Term Liabilities | 20,712 | 13,642 | 22,549 | 21,065 | 11,114 | 16,697 |
Total Liabilities | 40,622 | 29,711 | 35,149 | 40,160 | 25,971 | 25,458 |
Common Stock | 196 | 196 | 195 | 194 | 170 | 169 |
Additional Paid-in Capital | 18,019 | 17,696 | 17,186 | 16,552 | 10,211 | 9,945 |
Accumulated Other Comprehensive Income | -772 | -2,577 | 981 | -934 | 351 | -66 |
Retained Earnings | 24,818 | 22,402 | 21,924 | 18,055 | 15,793 | 13,155 |
Total Common Shareholders' Equity | 42,262 | 37,717 | 40,286 | 33,867 | 26,525 | 23,203 |
Minority Interest | 7 | 6 | 9 | - | - | - |
Shareholders' Equity | 42,269 | 37,723 | 40,295 | 33,867 | 26,525 | 23,203 |
Total Liabilities & Equity | 82,891 | 67,434 | 75,444 | 74,027 | 52,496 | 48,661 |
Total Debt | 17,587 | 11,495 | 16,735 | 20,485 | 9,101 | 10,906 |
Net Cash (Debt) | -16,505 | -10,454 | -15,595 | -19,581 | -7,740 | -9,861 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -47.29 | -30.07 | -45.13 | -60.07 | -24.77 | -33.22 |
Book Value | 42,262 | 37,717 | 40,286 | 33,867 | 26,525 | 23,203 |
Book Value Per Share | 121.10 | 108.50 | 116.58 | 103.90 | 84.89 | 78.18 |
Tangible Book Value | -19,041 | -11,363 | -18,685 | -25,713 | -13,488 | -15,221 |
Tangible Book Value Per Share | -54.56 | -32.69 | -54.07 | -78.88 | -43.17 | -51.28 |